Hillman Capital Management, Inc. — CVS HEALTH CORP CVS: Quarterly 13F Position History
Hillman Capital Management, Inc. has reported CVS HEALTH CORP (CVS) on 26 13F-HR filings in Pactolio's tracked window, first appearing in Q4 2019. As of Q1 2026, the position is sized at 67,462 shares ($4.8M market value, 3.36% of the equity book). Quarter-over-quarter share count change: 4,223 (-5.9%) .
- 67,462Shares Held (Latest Filing)
- $4.8MReported Market Value (Latest Filing)
- 3.36%Portfolio Weight (% of 13F Equity Book)
- 4,223Quarter-over-Quarter Share Change
- -$843.8KQuarter-over-Quarter Value Change
- 124,329Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 26 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 67,462 | 4,223 | -5.9% | $4.8M | 3.36% | $71.82 |
| Q4 2025 | 71,685 | 10,674 | -13.0% | $5.7M | 3.58% | $79.36 |
| Q3 2025 | 82,359 | 10,638 | -11.4% | $6.2M | 3.61% | $75.39 |
| Q2 2025 | 92,997 | 7,453 | -7.4% | $6.4M | 3.50% | $68.98 |
| Q1 2025 | 100,450 | 19,186 | -16.0% | $6.8M | 3.35% | $67.75 |
| Q4 2024 | 119,636 | 1,891 | -1.6% | $5.4M | 1.99% | $44.89 |
| Q3 2024 | 121,527 | 2,802 | -2.3% | $7.6M | 2.62% | $62.88 |
| Q2 2024 | 124,329 | +10,291 | +9.0% | $7.3M | 2.59% | $59.06 |
| Q1 2024 | 114,038 | +376 | +0.3% | $9.1M | 2.92% | $79.76 |
| Q4 2023 | 113,662 | +1,354 | +1.2% | $9.0M | 3.10% | $78.96 |
| Q3 2023 | 112,308 | +16,613 | +17.4% | $7.8M | 3.02% | $69.82 |
| Q2 2023 | 95,695 | 652 | -0.7% | $6.6M | 2.33% | $69.13 |
| Q1 2023 | 96,347 | +712 | +0.7% | $7.2M | 2.71% | $74.31 |
| Q4 2022 | 95,635 | 707 | -0.7% | $8.9M | 3.50% | $93.19 |
| Q3 2022 | 96,342 | 968 | -1.0% | $9.2M | 3.81% | $95.37 |
| Q2 2022 | 97,310 | 173 | -0.2% | $9.0M | 3.28% | $92.66 |
| Q1 2022 | 97,483 | 11,615 | -10.6% | $9.9M | 3.13% | $101.22 |
| Q4 2021 | 109,098 | 3,743 | -3.3% | $11.3M | 3.87% | $103.16 |
| Q3 2021 | 112,841 | +3,912 | +3.6% | $9.6M | 3.36% | $84.86 |
| Q2 2021 | 108,929 | +710 | +0.7% | $9.1M | 3.46% | $83.44 |
| Q1 2021 | 108,219 | +13,954 | +14.8% | $8.1M | 3.57% | $75.23 |
| Q4 2020 | 94,265 | +13,169 | +16.2% | $6.4M | 3.48% | $68.30 |
| Q3 2020 | 81,096 | +10,158 | +14.3% | $4.7M | 3.33% | $58.40 |
| Q2 2020 | 70,938 | +18 | +0.0% | $4.6M | 3.36% | $64.97 |
| Q1 2020 | 70,920 | 286 | -0.4% | $4.2M | 4.03% | $59.33 |
| Q4 2019 | 71,206 | — | — | $5.3M | 3.75% | $74.29 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did Hillman Capital Management, Inc. first disclose a CVS position in 13F-HR filings?
Hillman Capital Management, Inc. first reported CVS HEALTH CORP (CVS) on its 13F-HR filing for the period ending 2019-12-31 (Q4 2019). The position has appeared on 26 reported quarters within Pactolio's tracked window.
What was Hillman Capital Management, Inc.'s most recent quarter-over-quarter share-count change in CVS?
Between Q4 2025 and Q1 2026, Hillman Capital Management, Inc. reduced its CVS position by 4,223 shares (-5.9%), leaving 67,462 shares at a market value of $4.8M.
Does the implied price-per-share represent Hillman Capital Management, Inc.'s cost basis in CVS?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.